The iM4TB Foundation has been created in order to develop better and faster-acting medicines to fight all forms of tuberculosis.
They want to develop better and faster-acting medicines to fight tuberculosis and therefore bridge the gap between the scientific discovery and the market in order to provide affordable TB treatment to anyone in the world.
The process of bringing a new drug to the market once a new molecule has been identified includes several key mandatory steps that can take up to 8 years.
The full process includes the following phases:
Pre-clinical phases (trials on micro-organisms/animals).
It includes many steps such as the ADME profile, GMP manufacture, API, Toxicology, Production of clinical supplies (transformation into tablets) and preparation of regulatory documents for review and approval.
The pre-clinical phase is the most difficult part to be funded
This phase is crucial to allow human trials, however this is the most difficult part to be funded.
Nor pharmas companies, neither governments want to invest into it, this phase is often called THE DEATH VALLEY. This is the reason why the Fondation iM4TB has been created. it will bridge the financial gap and give the opportunity to our scientists to further develop our very promising drug candidate PBTZ 169.
Clinical phases (human trials). It involves the following steps:
